logo
logo

Nimble Therapeutics Appoints Dan Flynn As Chief Executive Officer and Brian Cali As Chief Development Officer

Mar 19, 2024•over 1 year ago

Position

Chief Development Officer

Company

Nimble Therapeutics

Brian Cali
MadisonTherapeuticsBiotechnology

Description

Nimble Therapeutics announces the appointment of Dan Flynn as Chief Executive Officer and Brian Cali as Chief Development Officer to the company’s Board of Directors. Both bring deep entrepreneurial and drug development track records that will guide Nimble as it continues to pursue its internal pipeline.

Company Information

Company

Nimble Therapeutics

Location

500 South Rosa Road

Madison, Wisconsin, United States

About

Nimble is a biotechnology company dedicated to delivering on the promise of peptide therapeutics. Leveraging a paradigm-shifting peptide drug discovery and development engine, Nimble is advancing its internal pipeline and continues to support several partnered programs.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months